Equity
AOCI
Thermo Fisher Scientific AOCI decreased by 2.0% to -$2.50B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.6%, from -$2.34B to -$2.50B. Over 5 years (FY 2020 to FY 2025), AOCI shows an upward trend with a -2.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2014
Last reportedQ1 2026May 1, 2026
How to read this metric
Fluctuations reflect changes in market conditions like currency rates or interest rates rather than operational efficiency.
Detailed definition
This represents the cumulative unrealized gains or losses that are excluded from the income statement, such as foreign c...
Peer comparison
Varies significantly based on global footprint and hedging strategies; peers with international operations will show higher volatility.
Metric ID:
aociHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.63B | -$2.65B | -$2.33B | -$2.34B | -$2.72B | -$2.93B | -$3.10B | -$3.05B | -$2.92B | -$3.03B | -$3.22B | -$2.76B | -$2.41B | -$2.48B | -$2.70B | -$2.34B | -$2.80B | -$2.80B | -$2.45B | -$2.50B |
| QoQ Change | — | -0.9% | +12.2% | -0.6% | -16.3% | -7.5% | -5.8% | +1.5% | +4.3% | -3.5% | -6.5% | +14.3% | +12.7% | -2.7% | -8.9% | +13.1% | -19.4% | -0.1% | +12.6% | -2.0% |
| YoY Change | — | — | — | — | -3.6% | -10.3% | -33.1% | -30.3% | -7.3% | -3.4% | -4.0% | +9.5% | +17.5% | +18.2% | +16.3% | +15.2% | -15.9% | -13.1% | +9.2% | -6.6% |
Range-$3.22B – -$2.33B
CAGR-1.1%
Avg YoY Growth-2.6%
Median YoY Growth-3.8%
AOCI at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's aoci?
- Thermo Fisher Scientific (TMO) reported aoci of -$2.50B in Q1 2026.
- How has Thermo Fisher Scientific's aoci changed year-over-year?
- Thermo Fisher Scientific's aoci decreased by 6.6% year-over-year, from -$2.34B to -$2.50B.
- What is the long-term trend for Thermo Fisher Scientific's aoci?
- Over 5 years (2020 to 2025), Thermo Fisher Scientific's aoci has grown at a -2.7% compound annual growth rate (CAGR), from -$2.81B to -$2.45B.
- What does aoci mean?
- Accumulated unrealized gains or losses not yet reflected in net income.